Cytek Biosciences Inc (CTKB) — Cash Flow Reinvestment Rate
Cytek Biosciences Inc (CTKB) has a Cash Flow Reinvestment Rate of 166.57x as of June 2025, reinvesting $17.99 Million (capex $1.58 Million plus investments $-16.41 Million) from operating cash flow of $108.00K. See how much free cash does Cytek Biosciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cytek Biosciences Inc Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Cytek Biosciences Inc across 4 annual periods. For the full cash flow conversion analysis, see CTKB cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Cytek Biosciences Inc (2020–2024)
Year-by-year capital reinvestment analysis for Cytek Biosciences Inc. See Cytek Biosciences Inc (CTKB) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.41x | $86.50 Million | $25.38 Million | $3.52 Million | ▼ -89.9% |
| 2023 | 33.87x | $178.85 Million | $5.28 Million | $4.83 Million | ▲ +518.4% |
| 2021 | 5.48x | $25.36 Million | $4.63 Million | $4.36 Million | ▲ +2582.8% |
| 2020 | 0.20x | $3.09 Million | $15.16 Million | $1.55 Million | — |